Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪2.06 B‬USD
−3.94USD
‪−235.94 M‬USD
‪49.92 M‬
Beta (1Y)
2.00

About Dyne Therapeutics, Inc.

CEO
John G. Cox
Headquarters
Waltham
Employees (FY)
141
Founded
2017
ISIN
US26818M1080
FIGI
BBG00NSGPJD0
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DYN is 25.67 USD — it has increased by 0.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dyne Therapeutics, Inc. stocks are traded under the ticker DYN.
Dyne Therapeutics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Dyne Therapeutics, Inc. has a max estimate of 47.00 USD and a min estimate of 25.00 USD.
DYN earnings for the last quarter are −0.99 USD whereas the estimation was −0.83 USD which accounts for −18.92% surprise. Estimated earnings for the next quarter are −0.92 USD. See more details about Dyne Therapeutics, Inc. earnings.
Yes, you can track Dyne Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, DYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dyne Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
DYN reached its all-time high on Jan 20, 2021 with the price of 32.32 USD, and its all-time low was 4.30 USD and was reached on Jun 2, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 141.00 employees. See our rating of the largest employees — is Dyne Therapeutics, Inc. on this list?